AbbVie IncABBV:NYQ

57.30
1.41 / 2.40%
18.50m
21.66%
--
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Sep 23 2014 19:22 BST.

Summary

As of last trade AbbVie Inc (ABBV:NYQ) traded at 57.30, 4.53% below its 52-week high of 60.02, set on Sep 17, 2014.

52-week range
Today
44.02
Sep 27 2013
60.02
Sep 17 2014
Markit short selling activity
Low
Medium
High
Open56.80
Day high58.27
Day low56.60
Bid57.29
Offer57.31
Previous close58.71
Average volume11.15m
Shares outstanding1.59bn
Free float1.57bn
P/E (TTM)22.65
Market cap93.53bn USD
EPS (TTM)2.59 USD
Annual div (TTM)1.68 USD
Annual div yield (TTM)2.86%
Div ex-dateJul 11 2014
Div pay-dateAug 15 2014
Next div ex-dateOct 10 2014
Next div pay-dateNov 17 2014
Last IC View
The last IC recommendation on AbbVie Inc shares was Hold at 4,801 on 16 Jul 2014
Read the full article
As of Sep 23 2014 19:22 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AbbVie Inc-2.25%+3.77%+10.81%+21.61%0.00%
S&P 500 INDEX-0.23%+0.30%+6.90%+17.18%+87.99%
USA/HEALTH CARE+0.38%+2.56%+9.65%+20.74%--
USA/PHARMACEUTICALS+0.70%+3.76%+6.96%+18.47%--
Data delayed at least 15 minutes, as of Sep 23 2014 19:07 BST.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.